Literature DB >> 19608674

Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.

Paquita Nurden, Alan T Nurden, Silvia La Marca, Margherita Punzo, Luciano Baronciani, Augusto B Federici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19608674      PMCID： PMC2770980          DOI： 10.3324/haematol.2009.012658

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model.

Authors:  Christel Poujol; Jerry Ware; Bernhard Nieswandt; Alan T Nurden; Paquita Nurden
Journal:  Exp Hematol       Date:  2002-04       Impact factor: 3.084

2.  Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.

Authors:  Paquita Nurden; Najet Debili; William Vainchenker; Regis Bobe; Raymonde Bredoux; Elisabeth Corvazier; Robert Combrie; Edith Fressinaud; Dominique Meyer; Alan T Nurden; Jocelyne Enouf
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

3.  Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.

Authors:  Julien Villeneuve; Anna Block; Marie-Caroline Le Bousse-Kerdilès; Sébastien Lepreux; Paquita Nurden; Jean Ripoche; Alan T Nurden
Journal:  Exp Hematol       Date:  2009-05-03       Impact factor: 3.084

4.  Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.

Authors:  Augusto B Federici; Pier M Mannucci; Giancarlo Castaman; Luciano Baronciani; Paolo Bucciarelli; Maria T Canciani; Alessandro Pecci; Peter J Lenting; Philip G De Groot
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

5.  Gene deletions correlate with the development of alloantibodies in von Willebrand disease.

Authors:  B B Shelton-Inloes; F F Chehab; P M Mannucci; A B Federici; J E Sadler
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  TMEM16B induces chloride currents activated by calcium in mammalian cells.

Authors:  Simone Pifferi; Michele Dibattista; Anna Menini
Journal:  Pflugers Arch       Date:  2009-05-28       Impact factor: 3.657

7.  Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.

Authors:  William B Slayton; Milin Patel; Martha Sola-Visner; Neil Harris; Angela Rivers; Robert R Montgomery; Kenneth D Friedman
Journal:  J Pediatr Hematol Oncol       Date:  2008-09       Impact factor: 1.289

8.  The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation.

Authors:  Shannon C Jackson; Gary D Sinclair; Stephanie Cloutier; Zhaoxia Duan; Margaret L Rand; Man-Chiu Poon
Journal:  Blood       Date:  2008-12-05       Impact factor: 22.113

Review 9.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.

Authors:  A Balduini; I Pallotta; A Malara; P Lova; A Pecci; G Viarengo; C L Balduini; M Torti
Journal:  J Thromb Haemost       Date:  2008-08-22       Impact factor: 5.824
View more
  1 in total

1.  Quantitative 3D microscopy highlights altered von Willebrand factor α-granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms.

Authors:  Maurice Swinkels; Ferdows Atiq; Petra E Bürgisser; Johan A Slotman; Adriaan B Houtsmuller; Cilia de Heus; Judith Klumperman; Frank W G Leebeek; Jan Voorberg; Arend Jan Gerard Jansen; Ruben Bierings
Journal:  Res Pract Thromb Haemost       Date:  2021-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.